Drawing for XIRXON

USPTO serial 79233972

XIRXON

Reviewed by CopyMark Law Group

Reg. 6835695Status 404
Filing date
Status date
Registration date
Sep 6, 2022
Examiner
RHIM,ANDREW
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XIRXON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 5, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jan 5, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 6, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 6, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 21, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 21, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 1, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 1, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 1, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 17, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 25, 2022DOCKASSIGNED TO EXAMINER—
Apr 19, 2022CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Feb 3, 2022CRTPREG. CANCELLED - RESTORED TO PENDENCY—
Jan 24, 2022APETASSIGNED TO PETITION STAFF—
Jan 20, 2022RCIIREQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED—
Jul 26, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jul 12, 2019FINPFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 14, 2019IRRHIRREGULARITY FROM IB EXAMINED BY MPU—
Mar 11, 2019IRFIIRREGULARITY ON FINAL DECISION RECEIVED FROM IB—
Feb 22, 2019XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 22, 2019XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 14, 2019GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jan 23, 2019ES7RTEAS SECTION 7 REQUEST RECEIVED—
Jan 16, 2019CHPNPOST PUBLICATION AMENDMENT – NOT ENTERED—
Jan 15, 2019APETASSIGNED TO PETITION STAFF—
Jan 15, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 21, 2018EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Dec 20, 2018CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Dec 19, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 9, 2018ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Aug 30, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 31, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 11, 2018NPUBNOTICE OF PUBLICATION—
Jun 28, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 26, 2018DOCKASSIGNED TO EXAMINER—
Jun 16, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 12, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 11, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 7, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance